MENU
BLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
bluebird bio (BLUE) Ownership - Who owns bluebird bio?
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
455 Grand Union Boulevard
Phone
+1 339 499-9300
Employees
323
Web
https://www.bluebirdbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.79M
P/E Ratio
N/A
Total Cash
70.65M
Projected Growth
N/A
Total Debt
368.4M
Revenue
53.12M
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash/Share
7.25
Total Debt/Equity
N/A
Revenue/Share
6.08 USD as % of share price
Fundamentals
BLUE
Capitalization
37.8M
P/E Ratio
N/A
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash
70.7M
Total Cash/Share
7.25
Total Debt
368M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.08%
Revenue
53.1M
ROE
N/A
Book Value
-5.79M
P/B Ratio
1.17
Cash Flow
N/A
Earnings
-36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.92M
Current Ratio
0.51
Current Revenue Per Employee
28298.67
Dividends Per Share - Security
N/A
EBITDA
-215.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
-11.02
Revenue To Assets
-54.29
Shares Held By Institutions
46.6M
Shares Outstanding - Current
9.74M
Total Liabilities
471M
Total Volume MTD
N/A
Value
1
Gain YTD
-51.079
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of next generation products based on the transformative potential of gene therapy
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Grand Union Boulevard
Phone
+1 339 499-9300
Employees
323
Web
https://www.bluebirdbio.com